COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 2893: Articles 28921-28930  | Next

Repeated population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
Silveira, M., Barros, A., Horta, B., Pellanda, L., Victora, G., Dellagostin, O., Struchiner, C., Burattini, M., Valim, A., Berlezi, E., Mesa, J., Ikeda, M. L., Mesenburg, M., Mantesso, M., Dall'Agnol, M., Bittencourt, R., Hartwig, F. P., Menezes, A. M., Hallal, P., Victora, C. G.
10.1101/2020.05.01.20087205 — Posted: 2020-05-06
Who is more susceptible to Covid-19 infection and mortality in the States?
Han, Y., Li, V. O. K., Lam, J. C. K., Guo, P., Bai, R., Fok, W. W. T.
10.1101/2020.05.01.20087403 — Posted: 2020-05-06
COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective?
Paredes Mogica, J. A., Nava, V., Torres, J.
10.1101/2020.05.01.20087411 — Posted: 2020-05-06 Discussion: Onsite
Correlating Covid-19 mortality and infection levels
Gadgil, M., Gadgil, C.
10.1101/2020.05.01.20087320 — Posted: 2020-05-06
National and state wise estimate of time varying reproduction number for COVID-19 in India during the nationwide lockdown.
Venkatesan, P.
10.1101/2020.05.01.20087197 — Posted: 2020-05-06
Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers
Catala, M., Pino, D., Marchena, M., Palacios, P., Urdiales, T., Cardona, P.-J., Alonso, S., Lopez-Codina, D., Prats, C., Alvarez Lacalle, E.
10.1101/2020.05.01.20087023 — Posted: 2020-05-06
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajoli, R. K., Pertinez, H., Arshad, U., Box, H., Tatham, L., Curley, P., Neary, M., Sharp, J., Liptrott, N. J., Valentijn, A., David, C., Rannard, S. P., Aljayyoussi, G., Pennington, S. H., Hill, A., Boffito, M., Ward, S. A., Khoo, S. H., Bray, P. G., O'Neill, P. M., Hong, W. D., Biagini, G., Owen, A.
10.1101/2020.05.01.20087130 — Posted: 2020-05-06
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019.
Gaibazzi, N., Martini, C., Mattioli, M., Tuttolomondo, D., Guidorossi, A., Suma, S., Dey, D., Palumbo, A., De Filippo, M.
10.1101/2020.05.01.20087114 — Posted: 2020-05-06
Early phases of COVID-19 are characterized by a reduction of lymphocyte populations and the presence of atypical monocytes
LOMBARDI, A., Trombetta, E., Cattaneo, A., Castelli, V., Palomba, E., Tirone, M., Mangioni, D., Lamorte, G., Manunta, M., Prati, D., Ceriotti, F., Gualtierotti, R., Costantino, G., Aliberti, S., Scaravilli, V., Grasselli, G., Gori, A., Porretti, L., Bandera, A.
10.1101/2020.05.01.20087080 — Posted: 2020-05-06 Discussion: Onsite
Cancer is associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
Gao, Y., Liu, M., Shi, S., Chen, Y., Sun, Y., Chen, J., Tian, J.
10.1101/2020.05.01.20087031 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).